66.53
Schlusskurs vom Vortag:
$65.78
Offen:
$67.08
24-Stunden-Volumen:
262.20K
Relative Volume:
0.23
Marktkapitalisierung:
$11.55B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$1.56B
KGV:
7.4974
EPS:
8.8738
Netto-Cashflow:
$-4.00M
1W Leistung:
-0.88%
1M Leistung:
-8.40%
6M Leistung:
-9.32%
1J Leistung:
-10.03%
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SOLV
Solventum Corp
|
66.56 | 11.41B | 8.35B | 1.56B | -4.00M | 8.8738 |
|
ISRG
Intuitive Surgical Inc
|
482.99 | 169.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.98 | 43.84B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
74.73 | 35.90B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.55 | 34.68B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
229.85 | 32.92B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Is Solventum Corporation Stock Underperforming the Dow? - Barchart
Solventum (SOLV) Q4 2025 adjusted diluted EPS reaches $1.57 on 3.5% organic sales growth - MSN
Profit Review: Is Solventum Corporation stock a good pick for beginners2026 Short Interest & Safe Entry Zone Tips - baoquankhu1.vn
Solventum announces launch of secondary offering of common stock - MSN
Major Funds and Insiders Signal Confidence in Solventum's Value - AD HOC NEWS
Aug Fed Impact: Is Solventum Corporation stock trending bullishEarnings Recap Summary & Verified Entry Point Signals - baoquankhu1.vn
JPMorgan Chase & Co. Has $50.11 Million Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
CIBC reiterates Solventum stock rating on market position strength By Investing.com - Investing.com Australia
CIBC reiterates Solventum stock rating on market position strength - Investing.com
SOLV SEC FilingsSolventum Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Jefferies reiterates Solventum stock rating citing margin upside By Investing.com - Investing.com Australia
Jefferies reiterates Solventum stock rating citing margin upside - Investing.com
Here’s Why Adding Solventum Shares to Your Portfolio Makes Sense Right Now - Bitget
Here's Why You Should Hold Solventum Stock in Your Portfolio Now - Yahoo Finance UK
Wells Fargo & Company Upgrades Solventum (NYSE:SOLV) to Hold - MarketBeat
Solventum Corporation $SOLV Shares Purchased by Davis Selected Advisers - MarketBeat
Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - MSN
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
UBS Maintains Solventum (SOLV) Neutral Recommendation - MSN
Curious about Solventum (SOLV) Q4 performance? Explore Wall Street estimates for key metrics - MSN
1 Healthcare Stock with Exciting Potential and 2 We Ignore - StockStory
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corporation $SOLV Position Lifted by Clifford Capital Partners LLC - MarketBeat
Solventum (SOLV) Just Overtook the 200-Day Moving Average - MSN
Independent Franchise Partners LLP Has $941.65 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Korea Investment CORP Sells 40,000 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
Barclays PLC Decreases Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Top Solventum Insider Quietly Makes a Major Bullish Move - TipRanks
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue - The Motley Fool
Solventum to Participate in the 2026 KeyBanc Healthcare Forum - GuruFocus
Insider Buying: Solventum (NYSE:SOLV) Director Buys 1,475 Shares of Stock - MarketBeat
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k By Investing.com - Investing.com Nigeria
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k - Investing.com
Director boosts Solventum (NYSE: SOLV) stake with 1,475-share open-market buy - Stock Titan
Intech Investment Management LLC Has $633,000 Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Will Solventum's (SOLV) Strong Q4, 2026 Outlook and Buyback Shift Its Capital Allocation Narrative - Sahm
JBC Technologies Named Solventum Premier Converter at MD&M West - Medical Device and Diagnostic industry
Executive equity activity at Solventum Corp (SOLV) as CHRO receives RSUs - Stock Titan
Solventum (NYSE: SOLV) CEO logs 105,963 RSU grant and tax share disposal - Stock Titan
Solventum (SOLV) legal chief gets 14,835 RSUs, covers taxes in shares - Stock Titan
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - MSN
Solventum’s Post-Spin Discount Looks Big, But Growth Must Show Up - Finimize
Solventum (NYSE:SOLV) Cut to Hold at Wall Street Zen - MarketBeat
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):